A good understanding of the cellular and molecular mechanisms involved in tumor blood vessel biology has established numerous strategies targeting some of the “main actors” such as VEGF/VEGFR2 or Ang2/Tie2. The gene discussed is ANGPT2; the disease is neoplasm.